Beyond memory T cells: mechanisms of protective immunity to tuberculosis infection
- PMID: 31141205
- DOI: 10.1111/imcb.12278
Beyond memory T cells: mechanisms of protective immunity to tuberculosis infection
Abstract
Tuberculosis (TB) is a serious infectious disease caused by infection with Mycobacterium tuberculosis, and kills more people annually than any other single infectious agent. Although a vaccine is available, it is only moderately effective and an improved vaccine is urgently needed. The ability to develop a more effective vaccine has been thwarted by a lack of understanding of the mechanism of vaccine-induced immune protection. Over recent decades, many novel TB vaccines have been developed and almost all have aimed to generate memory CD4 T cells. In this review, we critically evaluate evidence in the literature that supports the contention that memory CD4 T cells are the prime mediators of vaccine-induced protection against TB. Because of the lack of robust evidence supporting memory CD4 T cells in this role, the potential for B-cell antibody and "trained" innate cells as alternative mediators of protective immunity is explored.
Keywords: B-cell memory; BCG; memory T cells; trained immunity; tuberculosis.
© 2019 Australian and New Zealand Society for Immunology Inc.
Similar articles
-
The generation of T-cell memory to protect against tuberculosis.Immunol Cell Biol. 2019 Aug;97(7):656-663. doi: 10.1111/imcb.12275. Epub 2019 Jun 12. Immunol Cell Biol. 2019. PMID: 31127962 Review.
-
Natural and trained innate immunity against Mycobacterium tuberculosis.Immunobiology. 2020 May;225(3):151951. doi: 10.1016/j.imbio.2020.151951. Epub 2020 Apr 27. Immunobiology. 2020. PMID: 32423788 Review.
-
Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.Front Immunol. 2018 Oct 16;9:2371. doi: 10.3389/fimmu.2018.02371. eCollection 2018. Front Immunol. 2018. PMID: 30386336 Free PMC article.
-
Mycobacterial Lipoprotein Z Triggers Efficient Innate and Adaptive Immunity for Protection Against Mycobacterium tuberculosis Infection.Front Immunol. 2019 Jan 16;9:3190. doi: 10.3389/fimmu.2018.03190. eCollection 2018. Front Immunol. 2019. PMID: 30700988 Free PMC article.
-
The Profile of T Cell Responses in Bacille Calmette-Guérin-Primed Mice Boosted by a Novel Sendai Virus Vectored Anti-Tuberculosis Vaccine.Front Immunol. 2018 Aug 3;9:1796. doi: 10.3389/fimmu.2018.01796. eCollection 2018. Front Immunol. 2018. PMID: 30123219 Free PMC article.
Cited by
-
Nanomaterials-based vaccines to target intracellular bacterial pathogens.Front Microbiol. 2022 Nov 18;13:1040105. doi: 10.3389/fmicb.2022.1040105. eCollection 2022. Front Microbiol. 2022. PMID: 36466676 Free PMC article. Review.
-
Anti-tumor memory CD4 and CD8 T-cells quantified by bulk T-cell receptor (TCR) clonal analysis.Front Immunol. 2023 Mar 23;14:1137054. doi: 10.3389/fimmu.2023.1137054. eCollection 2023. Front Immunol. 2023. PMID: 37033929 Free PMC article.
-
Phenotype of Peripheral NK Cells in Latent, Active, and Meningeal Tuberculosis.J Immunol Res. 2021 Apr 27;2021:5517856. doi: 10.1155/2021/5517856. eCollection 2021. J Immunol Res. 2021. PMID: 34007850 Free PMC article.
-
BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance.Nat Immunol. 2024 Jan;25(1):41-53. doi: 10.1038/s41590-023-01700-0. Epub 2023 Nov 30. Nat Immunol. 2024. PMID: 38036767 Free PMC article.
-
A subunit vaccine Ag85A-LpqH focusing on humoral immunity provides substantial protection against tuberculosis in mice.iScience. 2024 Dec 20;28(1):111568. doi: 10.1016/j.isci.2024.111568. eCollection 2025 Jan 17. iScience. 2024. PMID: 39868033 Free PMC article.
References
-
- Kirman JR, Henao-Tamayo MI, Agger EM. The memory immune response to tuberculosis. Microbiol Spectr 2016; 4. https://doi.org/10.1128/microbiolspec.TBTB2-0009-2016
-
- Rodrigues LC, Pereira SM, Cunha SS, et al. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet 2005; 366: 1290-1295.
-
- WHO. BCG vaccines: WHO position paper - February 2018. WHO Wkly Epidemiol Rec 2018; 93: 73-96.
-
- Mangtani P, Abubakar I, Ariti C, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis 2014; 58: 470-480.
-
- Mangtani P, Nguipdop-Djomo P, Keogh RH, et al. The duration of protection of school-aged BCG vaccination in England: a population-based case-control study. Int J Epidemiol 2018; 47: 193-201.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials